Serum ferritin is inversely correlated with serum adiponectin level: Population-based cross-sectional study

Disease Markers

Volumn 27, Issue 6, 2009, Pages 303-310

  Ku, Bon Jeong ^a   Kim, Seul Young ^a   Lee, Tae Yong ^a   Park, Kang Seo ^b  

^a Chungnam National University   (South Korea)

^b Eulji University School of Medicine   (South Korea)

Author keywords

Adiponectin; Diabetes mellitus; Ferritin

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FERRITIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOASCORBIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS;

EID: 77249138221     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2009-0676     Document Type: Article

References (33)

1. J.D. Cook, C.H. Flowers and B.S. Skikne, The quantitative assessment of body iron, Blood 101 (2003), 3359-3364.
2. T.P. Tuomainen, K. Nyyssonen, R. Salonen, A. Tervahauta, H. Korpela, T. Lakka, G.A. Kaplan and J.T. Salonen, Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men, Diabetes Care 20 (1997), 426-428.
3. M. Jehn, J.M. Clark and E. Guallar, Serum ferritin and risk of the metabolic syndrome in U.S. adults, Diabetes Care 27 (2004), 2422-2428.
4. M. Haidari, E. Javadi, A. Sanati, M. Hajilooi and J. Ghanbili, Association of increased ferritin with premature coronary stenosis in men, Clin Chem 47 (2001), 1666-1672.
5. M.J. Williams, R. Poulton and S. Williams, Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women, Atherosclerosis 165 (2002), 179-184.
6. E.S. Ford and M.E. Cogswell, Diabetes and serum ferritin concentration among U.S. adults, Diabetes Care 22 (1999), 1978-1983.
7. X. Chen, T.O. Scholl and T.P. Stein, Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women: The Camden study, Diabetes Care 29 (2006), 1077-1082.
8. R.F. Gillum, Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men-the Third National Health and Nutrition Examination Survey, Int J Obes Relat Metab Disord 25 (2001), 639-645.
9. T. Iwasaki, A. Nakajima, M. Yoneda, Y. Yamada, K. Mukasa, K. Fujita, N. Fujisawa, K. Wada and Y. Terauchi, Serum ferritin is associated with visceral fat area and subcutaneous fat area, Diabetes Care 28 (2005), 2486-2491.
10. T. Kadowaki and T. Yamauchi, Adiponectin and adiponectin receptors, Endocr Rev 26 (2005), 439-451.
11. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki and K. Tobe, Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome, J Clin Invest 116 (2006), 1784-1792.
12. Y. Yamamoto, H. Hirose, I. Saito, K. Nishikai and T. Saruta, Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population, J Clin Endocrinol Metab 89 (2004), 87-90.
13. K. Hara, M. Horikoshi, T.Yamauchi, H.Yago, O. Miyazaki, H. Ebinuma, Y. Imai, R. Nagai and T. Kadowaki, Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome, Diabetes Care 29 (2006), 1357-1362.
14. M. Daimon, T. Oizumi, T. Saitoh, W. Kameda, A. Hirata, H. Yamaguchi, H. Ohnuma, M. Igarashi, M. Tominaga and T. Kato, Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study, Diabetes Care 26 (2003), 2015-2020.
15. M. Matsubara, S. Maruoka and S. Katayose, Decreased plasma adiponectin concentrations in women with dyslipidemia, J Clin Endocrinol Metab 87 (2002), 2764-2769.
16. W.S. Yang, W.J. Lee, T. Funahashi, S. Tanaka, Y. Matsuzawa, C.L. Chao, C.L. Chen, T.Y. Tai and L.M. Chuang, Plasma adiponectin levels in overweight and obese Asians, Obes Res 10 (2002), 1104-1110.
17. E. DeMaeyer and M. Adiels-Tegman, The prevalence of anaemia in the world, World Health Stat Q 38 (1985), 302-316.
18. American Diabetes Association, Diagnosis and classification of diabetes mellitus, Diabetes Care 29(1) (2006), S43-S48.
19. W.T. Friedewald, R.I. Levy and D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem 18 (1972), 499-502.
20. G.R. Hajer, T.W. van Haeften and F.L.Visseren, Adipose tissue dysfunction in obesity, diabetes, and vascular diseases, Eur Heart J 29 (2008), 2959-2971.
21. N. Rasouli and P.A. Kern, Adipocytokines and the metabolic complications of obesity, J Clin Endocrinol Metab 93 (2008), S64-S73.
22. A.E. Schutte, H.W. Huisman, R. Schutte, L. Malan, J.M. Van Rooyen, N.T. Malan and P.E. Schwarz, Differences and similarities regarding adiponectin investigated in African and Caucasian women, Eur J Endocrinol 157 (2007), 181-188.
23. D. Rothenbacher, H. Brenner, W. Marz and W. Koenig, Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers, Eur Heart J 26 (2005), 1640-1646.
24. A.J. Hanley, D. Bowden, L.E. Wagenknecht, A. Balasubramanyam, C. Langfeld, M.F. Saad, J.I. Rotter, X. Guo, Y.D. Chen, M. Bryer-Ash, J.M. Norris and S.M. Haffner, Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans, J Clin Endocrinol Metab 92 (2007), 2665-2671.
25. M. Bluher, C.J. Williams, N. Kloting, A. Hsi, K. Ruschke, A. Oberbach, M. Fasshauer, J. Berndt, M.R. Schon, A. Wolk, M. Stumvoll and C.S. Mantzoros, Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training, Diabetes Care 30 (2007), 3110-3115.
26. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, Y. Okamoto, H. Iwahashi, H. Kuriyama, N. Ouchi, K. Maeda, M. Nishida, S. Kihara, N. Sakai, T. Nakajima, K. Hasegawa, M. Muraguchi, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Hanafusa and Y. Matsuzawa, Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients, Arterioscler Thromb Vasc Biol 20 (2000), 1595-1599.
27. M.B. Schulze, E.B. Rimm, I. Shai, N. Rifai and F.B. Hu, Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes, Diabetes Care 27 (2004), 1680-1687.
28. L. Sun, O.H. Franco, F.B. Hu, L. Cai, Z. Yu, H. Li, X. Ye, Q. Qi, J.Wang, A. Pan, Y. Liu and X. Lin, Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese, J Clin Endocrinol Metab 93 (2008), 4690-4696.
29. J.M. Ferńandez-Real, W. Ricart-Engel, E. Arroyo, R. Balanç, R. Casamitjana-Abella, D. Cabrero, M. Ferńandez-Castãner and J. Soler, Serum ferritin as a component of the insulin resistance syndrome, Diabetes Care 21 (1998), 62-68.
30. A. Yildirim, M. Bilici, K. Cayir, V. Yanmaz, S. Yildirim and S.B. Tekin, Serum adiponectin levels in patients with esophageal cancer, Jpn J Clin Oncol 39 (2009), 92-96.
31. D. Barb, C.J. Williams, A.K. Neuwirth and C.S. Mantzoros, Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence, AmJ Clin Nutr 86 (2007), s858-s866.
32. K.M. Choi, J. Lee, K.W. Lee, J.A. Seo, J.H. Oh, S.G. Kim, N.H. Kim, D.S. Choi and S.H. Baik, Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans, Clin Endocrinol (Oxf) 61 (2004), 75-80.
33. T. Pischon, G.S. Hotamisligil and E.B. Rimm, Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year, Clin Chem 49 (2003), 650-652.